Companies: 10,795·Total market cap: $144.5T
Checkpoint Therapeutics, Inc.

Checkpoint Therapeutics, Inc.

CKPTNASDAQHealthcare
$4.26
+$0.00(+0.00%)
Market Cap$367723200
P/E Ratio
52W High$4.5
52W Low$1.8
Overview

Checkpoint Therapeutics, Inc. (CKPT) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · CKPT · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-19.85ckpt eps ttm · ckpt earnings per shareEarnings history
PE Ratio (TTM)ckpt pe ratio ttm · ckpt price to earningsPE Ratio deep dive
Revenue (TTM)41000.00ckpt revenue ttm · ckpt annual revenueFull revenue history
Dividend YieldNo Dividenddoes ckpt pay dividends · ckpt dividend yieldDividend history
Shares Outstanding39.7Mckpt shares outstanding · ckpt floatShares outstanding history
Next EarningsTBAckpt earnings date · ckpt next earningsEarnings history

Financial Snapshot

Full Financials
FY 2024Revenue$41000.00▼ 60.19% YoY
202220232024
checkpoint therapeutics, inc. revenue · ckpt revenue 2024
FY 2024Net Income-$56.2M▼ 8.47% YoY
202220232024
checkpoint therapeutics, inc. net income · ckpt profit 2024
FY 2024EPS$-1.42▲ +48.74% YoY
202220232024
ckpt eps · checkpoint therapeutics, inc. earnings per share 2024
TTM:Revenue: $41000.00Net Income: -$56.5MEPS: $-19.85View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy7 analystsis ckpt a buy · ckpt analyst rating
Strong Buy
0
Buy
5
Hold
2
Sell
0
Strong Sell
0
12-Month Price Target
$4.10Low
$4.26Current
$4.10Avg Target3.76% downside
$4.10High
ckpt price target · ckpt 12 month forecast

Total: 7 · Buy rate: 71.4%

The CKPT analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $4.10, representing -3.76% downside from the current price of $4.26.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.00%
3M+5.45%
YTD+29.48%
1Y+107.80%
5Y-78.70%

About Checkpoint Therapeutics, Inc.

CEOJames F. Oliviero III,
IPO DateDec 19, 2016
Employees24
CountryUS

Checkpoint Therapeutics, Inc. is a clinical-stage company specializing in immunotherapy and targeted oncology. Its mission involves discovering, advancing, and bringing to market innovative therapeuti…

what is checkpoint therapeutics, inc. · ckpt stock overview · checkpoint therapeutics, inc. company profile · who is checkpoint therapeutics, inc. ceo · ckpt NASDAQ · checkpoint therapeutics, inc. headquarters · checkpoint therapeutics, inc. business segments

About Stock Overview & Key Data

Checkpoint Therapeutics, Inc. (CKPT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 19, 2016. As of the latest trading session, CKPT stock price is $4.26, with a market capitalization of $367.7M. The stock has returned +107.80% over the past 12 months and +29.48% year-to-date.

According to 7 Wall Street analysts, the consensus rating for Checkpoint Therapeutics, Inc. stock is Buy, with an average 12-month price target of $4.10. In fiscal year 2024, Checkpoint Therapeutics, Inc. reported revenue of $41000.00 and net income of -$56.2M. For detailed data — including Checkpoint Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Checkpoint Therapeutics, Inc. (CKPT) stock price is $4.26. The stock is traded on NASDAQ under the ticker symbol CKPT. The 52-week range is $1.80 – $4.50.

CKPT stock priceCKPT quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice